Call for Abstract

20th World Conference on Pharmaceutical Chemistry and Drug Design, will be organized around the theme “Exceeding the Vision in Drug and Pharmaceutical Chemistry”

Pharm Chem 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Pharm Chem 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Drug design is an inventive process of medication discovered by biological target. It is also known as rational drug design or rational design. The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense. Drug design relies on the knowledge of the three-dimensional structure of bimolecular targets. The drug is an organic molecule, when it is predicament to target site it can either inhibit or activate the function of a biomolecule which effects in therapeutic benefit.

  • Track 1-1Research & development in drug designing
  • Track 1-2Drug targets
  • Track 1-3Drug designing docking
  • Track 1-4Types of drug design
  • Track 1-5Structural based drug designing
  • Track 1-6Pharmacoepidemiology

Organic chemistry is a chemistry subdiscipline involving the scientific study of the structure, properties, and reactions of organic compounds and organic materials, i.e., matter in its various forms that contain carbon atoms. It includes many physical and chemical method to determine the compound and materials. Study of molecules includes both physical properties and chemical properties and uses similar methods, so as to evaluate chemical reactivity. The variety of compounds studied in organic chemistry include hydrocarbons, as well as myriad compositions based always on carbon. In addition, organic chemistry involves further organometallics the lanthanides, but especially transition metals (zinc, copper, nickel, cobalt, titanium and chromium).

  • Track 2-1Organometallic chemistry
  • Track 2-2Techniques in organic chemistry
  • Track 2-3 Chemical reactions in pharma organic chemistry
  • Track 2-4Future aspects of organic chemistry

The term drug targets regularly used in medicinal research to describe the native protein in the body whose activity is modified by a drug resulting in a distinct effect, which may be a desirable therapeutic effect or an unwanted side effect. In this context, the biological target is often referred to as a biological target. The most common drug targets are G-protein couple receptor, enzymes, ligand gated channels, voltage gated channels, ion channels, nuclear hormone receptor and membrane transport proteins

  • Track 3-1Drug targeting
  • Track 3-2Drug toxicity
  • Track 3-3Drug designing
  • Track 3-4Drug design strategies for targeting g-protein-coupled receptors
  • Track 3-5Biological targets
  • Track 3-6Rational drug design

Nanotechnology has now introduced to develop medicine. Nanotechnology contains the use of materials with essential length scales in the nanometer measurement which demonstrate significantly changed properties associated to micron structured materials. Such materials can include particles, fibers, grain sizes, etc. This session highlighted the progressions nanotechnology is making in medicine in such fields as disease prevention, diagnosis, and treatment including (but not limited to) drug delivery, tissue engineering, implants, sensors, cancer treatment, an but not limited to) drug delivery, tissue engineering, transplants, sensors, cancer treatment, and toxic

  • Track 4-1Current research in nanotechnology
  • Track 4-2Nanotechnology methods in drug design
  • Track 4-3optimization techniques in drug discovery
  • Track 4-4Future aspects of drug discovery and nanotechnology

Pharmacovigilance is that branch of pharmacology that focuses on analysis, detection and prevention of adverse effects caused by pharmaceutics. Adverse drug reactions (ADRs) are a major cause of patient related morbidity and mortality. Reporting of ADRs is considered to be an important step in maintaining and achieving a safe drug therapy use. Nowadays, Pharmacovigilance hugely emphasizes on challenges like Mass treatment regimens, Un-labelled and Off-labelled indications, Nutritional aspects, New drugs, Adherence, Co-morbidities and Drug resistances. Medication errors such as misuse, overdose, abuse of a drug and drug exposure are some of the reasons responsible for ADRs. The main objective is to generate independent, evidence-based recommendations on the safety of medicines and to monitor benefit-risk profile of different pharmaceutics. Pharma Chem Conference


  • Track 5-1Adverse Drug Reactions
  • Track 5-2Adverse Events
  • Track 5-3Pharmacogenetics and Pharmacogenomics
  • Track 5-4Pharmacoepidemiology

Enzyme reaction is the increase in the amount of a chemical reaction by the active site of a protein. The protein catalyst (enzyme) may be part of a multi-subunit compound, and/or may rapidly or permanently associate with a Cofactor (example: xylose). Catalysis of enzyme reactions in the cell is vigorous due to the very low reaction rates of the uncatalyzed reactions at room temperature and pressure. A main driver of protein development is the optimization of such catalytic activities via protein dynamics. The mechanism of enzyme catalysis is analogous in principle to other types of chemical catalysis. By provided that an alternative reaction routes the enzyme reduces the energy required to reach the highest energy transformation state of the reaction. The reduction of activation energy increases the quantity of reactant molecules that achieve a sufficient level of energy, such that they reach the activation energy and form the product.

  • Track 6-1Characterization of enzyme reaction
  • Track 6-2Methods in enzyme reaction
  • Track 6-3Biocatalysis in pharma chemistry
  • Track 6-4Enzyme kinetics and mechanism in pharma

The character of atoms and the changes that occur at intermissions of such elements on the molecular level and non-natural chemistry of nanomaterials. Conversely, modification of peptide materials by Thiol-X chemistry additionally involves the techniques of those substances which are endued with intrinsic voids, ideal materials, and real materials. With the chemistry of tissue adhesive materials, there are endless prospects for making numerous properties of medicative chemistry with carbons and fullerene derivatives. Biological chemistry isn't just involved with the revelation of biological phenomena to Materialistic Chemistry is a discipline of frontiers in inorganic synthetic chemistry that seeks to reveal utilize the studies of drug design and drug discovery. The artificial medicative chemistry endeavors to form new technology which will form the commercial foundation to alter North American country to foster a wholesome natural perspective and philosophy and a healthy property society.

  • Track 7-1Advances in materialistic and synthetic chemistry
  • Track 7-2Concepts in pharma chemistry
  • Track 7-3Polymer chemistry
  • Track 7-4Techinques in synthetic

The term "cancer" refers to a group of diseases that include irregular cell growth with the latent spread to other parts of the body. As each cancer consists of a various cell types highly effective at developing confrontation to both drug and radiation therapy, it is a particularly difficult disease to treat. The challenge for the field of medicinal chemistry is to design drugs capable of selectively targeting cancer cells while evading multidrug resistance pathways. Using recent observations into the unique attributes of cancer cells, Medicinal Chemistry is pursuing anti-tumor agents of high specificity to help design appropriately targeted, selective chemotherapeutics. Current programs involve a various array of anti-cancer targets, such as lipid and protein kinases, microtubules, topoisomerases, hypoxia inducible factors, bromodomains and histone acetyltransferases.

  • Track 8-1Chemotherapy in medicinal Chemistry
  • Track 8-2Cancer diagnosis in medicinal Chemistry
  • Track 8-3Cancer treatment with medicinal Chemistry
  • Track 8-4Methods in Cancer research
  • Track 8-5Keys aspects in Pharma medicinal chemistry

Computer aided drug design and Advanced Instrumentation is that the most basic goal is to predict whether a given bioactive molecule can bind to a target or not. Study in drug design or biomarkers in drug design measures the conformation of the little molecule and to model conformational changes within the biological target which will occur once the little molecule binds thereto. Recent advances in CADD with the utilization of high performance computing technology and Insilco molecular design computer code and tools offer might optimize the parameters for the molecular mechanics calculations and additionally provide an estimation of the electronic properties (electrostatic potential, polarizability, etc.) of the drug molecule that may influence binding affinity within the use of ultrasound in medicinal chemistry. High-resolution 1H-NMR chemical analysis and X-Ray absorption chemical analysis ways may additionally be accustomed offer semi-quantitative prediction of the required affinity

  • Track 9-1 Bioinformatics in CADD
  • Track 9-2Ligand based CADD
  • Track 9-3Homology modeling
  • Track 9-4Steps Involved in CADD
  • Track 9-5Drug Design Software

The margins between present developments in medicinal chemistry and investigative medicinal chemistry between inanimate and living matter may be a major feature of the convergence between engineering and biotechnology. The most intention of recent advances in medicinal chemistry is to emphasize that though creating life may be a continual project which measures refined process within the underlying hypothetical assumptions. This comparison is supposed to contribute to an improved understanding of the cultural problems at stake within the convergence between Nano and biotechnologies.  It suggests that the limit between life and inanimate matter remains a stock in which the advancement in Pharmacogenomics and Pharmacoproteomic   research on drugs will tends to new discoveries.


  • Track 10-1Medicinal chemistry in drug designing
  • Track 10-2Clinical chemistry in drug discovery
  • Track 10-3Forencsic chemistry in drug discovery &designing
  • Track 10-4Organic chemistry and inorganic chemistry in drug designing
  • Track 10-5Structural Chemistry in drug discovery
  • Track 10-6Electrochemistry in drug discovery

Chemoinformatics plays a vital link between made-up design and in drug design through mining of information from the data and translate into knowledge. Derivation of information and knowledge is only one aspect of chemoinformatic. The use of consequent knowledge in a design and selection support role is an important part of the drug design cycle. The main processes within drug discovery are lead documentation, where a lead is something that has activity in the low micro molar range, and lead optimization, which is the process of transforming a lead into a drug candidate. Chemo informatics methods can be used proactively to designing and filter the most appropriate compounds to work within the real world.

  • Track 11-1Information aquisation and process of generating and collecting data
  • Track 11-2Prediction of physical,chemical and biological properties of chemical compounds
  • Track 11-3Elucidation of the structure of a compounds based on data
  • Track 11-4Structure,similarity and diversity searching from chemical database
  • Track 11-5Docking- interaction between two macromolecules

Clinical trials are tests done in clinical research. Such ultimate biomedical or interactive research studies on human participants are designed to answer precise questions about biomedical or behavioral interferences, with new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that certification further study and comparison. Clinical trials generate data on safety and efficacy.

Regulatory affairs are completely a new profession which established from the desire of governments to secure public health by monitoring the protection and value of products in areas together with pharmaceutical, pesticides, medical devices, agrochemicals, cosmetics and other related medicines

  • Track 12-1Discovery and preclinical testing phases
  • Track 12-2Pre-clinical testing
  • Track 12-3Data collection and quality control
  • Track 12-4Regulatory guidelines
  • Track 12-5Regulations in pharmacy

Categorizing drug targets plays crucial roles in designing new drugs and opposing diseases. Unfortunately, our current understanding about drug targets is far from complete. Screening drug targets in the lab is an expensive and time-consuming procedure. In the past decade, the accumulation of various types of study of science related data makes it possible to develop computational approaches to predict drug targets. Non-communicable diseases such as cancer, atherosclerosis and diabetes are responsible for most important social and health disorder as millions of people are dying every year. Out of which, atherosclerosis is the leading cause of deaths globally. The lipid irregularity is one of the most important adjustable risk factors for atherosclerosis. Both genetic and conservation components are associated with the development of atherosclerotic signs 

  • Track 13-1Drug carrier
  • Track 13-2Thinfilm drug delivery
  • Track 13-3Other controlled drug delivery systems
  • Track 13-4Liposomal & target delivery system
  • Track 13-5Identification &validation of drug targets

The process by which a drug is distributed can have a important effect on its efficacy Some drugs have an optimum concentration range within which extreme benefit is derived, and concentrations above or below this range can be noxious or produce no therapeutic benefit at all. On the other hand, the very slow improvement in the efficacy of the treatment of severe diseases, has optional a growing need for a multidisciplinary approach to the delivery of therapeutics to targets in tissues. These nanoparticles would be loaded with drugs and plagued to specific parts of the body where there is completely diseased tissue, thereby avoiding interaction with healthy tissue. The goal of a targeted drug delivery system is to extend, localize, target and have a vulnerable drug interaction with the diseased muscle

  • Track 14-1Targeted drug delivery
  • Track 14-2Proteins and surfaces
  • Track 14-3Pulmonary drug delivery
  • Track 14-4Blood brain barrier delivery
  • Track 14-5Antibody targeted drug conjugates
  • Track 14-6Genedelivery

Proteomics, the large-scale analysis of proteins, contributes expressively to our understanding of gene function in the post-genomic era. Proteomics can be divided into three main areas: (1) protein micro-characterization for large-scale certification of proteins and their post-translational changes; (2) 'differential display' proteomics for comparison of protein levels with potential application in a extensive range of diseases; and (3) studies of protein–protein interactions using methods such as mass spectrometry or the yeast two-hybrid system. Proteomics technologies are under nonstop progresses and new skills are introduced. Nowadays high quantity acquisition of proteome data is possible.


  • Track 15-1Emerging trends in proteomics
  • Track 15-2Bioinformatics for proteomics
  • Track 15-3Current research methodologies in proteomics
  • Track 15-4Structural proteomics
  • Track 15-5Practical applications of proteomics

The Present Marketing practice in the Pharmaceutical sector, examining both customer and doctor slanted towards promotion. The present examples of marketing practices and their impact on consumer and doctor behavior. It identifies negative impact of these practices which include misleading advertising, disease shove and escalating costs. It goes on to maintain the need for an independently monitored code of practice for marketers in the pharmaceutical sector and a great degree of consumer education for both end users and those Prescribing drugs

  • Track 16-1R&D investments
  • Track 16-2Generic Versus branded pharmaceutical products
  • Track 16-3Biopharmaceuticals and challenges
  • Track 16-4Market revenue forecast
  • Track 16-5Pharma economical foot print
  • Track 16-6Drug pricing
  • Track 16-7Vaccine R&D
  • Track 16-8World wide prescription drug & sales